PTX3 and ventilator-associated pneumonia: Tekerek et al. found that PTX-3 serum levels were significantly higher in pediatric patients with microbiologically confirmed VAP compared to children with suspected VAP and controls, where an optimal cut-off value for PTX-3 in serum was reported to be 4.19 ng/mL.